Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (Symbol: TDOC), where a total of 33,577 contracts have traded so far, representing approximately 3.4 million underlying shares. That amounts to about 45.9% of TDOC's average daily trading volume over the past month of 7.3 million shares. Particularly high volume was seen for the $5 strike call option expiring February 06, 2026 , with 23,913 contracts trading so far today, representing approximately 2.4 million underlying shares of TDOC. Below is a chart showing TDOC's trailing twelve month trading history, with the $5 strike highlighted in orange: Cardinal Health, Inc. (Symbol: CAH) options are showing a volume of 8,388 contracts thus far today. That number of contracts represents approximately 838,800 underlying shares, working out to a sizeable 45.5% of CAH's average daily trading volume over the past month, of 1.8 million shares. Particularly high volume was seen for the $250 strike call option expiring March 20, 2026, with 6,804 contracts trading so far today, representing approximately 680,400 underlying shares of CAH. Below is a chart showing CAH's trailing twelve month trading history, with the $250 strike highlighted in orange: And Scorpio Tankers Inc (Symbol: STNG) options are showing a volume of 4,879 contracts thus far today. That number of contracts represents approximately 487,900 underlying shares, working out to a sizeable 45.4% of STNG's average daily trading volume over the past month, of 1.1 million shares. Especially high volume was seen for the $67.50 strike call option expiring February 20, 2026, with 2,282 contracts trading so far today, representing approximately 228,200 underlying shares of STNG. Below is a chart showing STNG's trailing twelve month trading history, with the $67.50 strike highlighted in orange: For the various different available expirations for TDOC options, CAH options, or STNG options, visit Stock...

Igor Alecsander/iStock Unreleased via Getty Images Apple ( AAPL ) is working on an update to its CarPlay app, which will allow users to communicate with a third-party chatbot, such as OpenAI's ( OPENAI ) ChatGPT or Google's ( GOOG )( GOOGL ) Gemini, according to Bloomberg. For example, drivers could ask ChatGPT for nearby dining recommendations or request Gemini to search for cheap airline tickets. CarPlay might be able to support these AI chatbots within the next few months, according to the report , which cited people familiar with the matter. Up to this point, drivers using CarPlay have only been able to communicate with Siri. Apple still does not plan to allow users to remove or replace the Siri button on CarPlay. Rather, drivers will open the third-party app through voice control, the report added. Last year, Apple launched CarPlay Ultra that extends its interface across all car displays. It is only available in select Aston Martin models at this point but is expected to appear in certain Hyundai and Kia models later this year. Tesla ( TSLA ) is also reportedly working to support CarPlay as well. More on Apple Apple: The Pros And Cons Of Investing Right Now - Downgrading To Hold Apple: Capital-Light AI Arbitrage Ignites iPhone Supercycle Alpha The iPhone 17 Changed Everything For Apple - See China (Rating Upgrade) Apple heads to moon after NASA chief approves iPhones for upcoming missions Dividend Roundup: Apple, Ford, 3M, IBM, and more

Shocking Video: Grenade Tossed Into French Beauty Salon, Injures Six Absolutely horrifying footage on X shows a masked man tossing a grenade into a beauty salon in Grenoble , in southeastern France. Agence France-Presse reports that six people were injured. In Grenoble, authorities are investigating a grenade attack at a beauty salon that left six people with injuries, including a 5-year-old child. Western media outlets have largely ignored the grenade attack and have mostly focused on President Trump's now-deleted meme video targeting the Obamas on Friday. Former Member of the Chamber of Representatives of Belgium, Dries Van Langenhove, wrote on X : Grenades thrown into barber shops, beauty salons and kebabs are becoming so prevalent in Western Europe that they barely make the news. Police are losing control over vast swathes of territory and when they do, nature takes over. For most humans, including all of those imported from Africa and the Middle-East, that means violent gangs will take over and demand protection money from businesses. When they don't pay, grenades. This will be the new normal for our children unless we deport all of the hostile invaders and punish the politicians that opened the floodgates. Video of the shocking attack : BREAKING: 🇫🇷 Six people have been injured after a man launched a grenade into a beauty salon in Grenoble, France. The attack occurred shortly after 3 p.m. on Friday. Among the injured is a five-year-old child. pic.twitter.com/VdlC4CWeiK — Remix News & Views (@RMXnews) February 6, 2026 There's still no official word on whether the attacker was a migrant. Still, a grenade attack inside a beauty salon is a reminder of how public safety is deteriorating in pockets of France and intensifying the backlash across Europe over nation-killing mass migration . French President Emmanuel Macron's globalist policies are harming working poor citizens and prioritizing migrants over national security; hence, a byproduct of outrage has been the ...

Bank loans remain a popular place for investors to find attractive yields — but average investors can't just buy them. Instead, they'll have to access the loans — which may also be referred to as senior loans or syndicated loans — through exchange-traded funds or mutual funds. The underlying assets are debt instruments issued by well-known companies, like American Airlines and X, that are considered below investment grade. They are structured and syndicated by banks to large groups of lenders, such as mutual funds and institutional investors. They typically have floating interest rates tied to the secured overnight financing rate (SOFR). Fortunately, retail investors have a plethora of choices these days — there are 16 bank loan ETFS and many more mutual funds, said Brian Moriarty, principal, fixed income strategies at Morningstar. "We've seen more launches recently from traditional asset managers launching actively-managed bank loan funds," he said. "There's been a couple of them in the last couple of years, more than there was previously, and that's because more and more investors just want an ETF for everything." 'High levels of income' Both Invesco and Nuveen recently called out the assets as a place to be right now. Saira Malik, chief investment officer at Nuveen, pointed out in her weekly commentary on Jan. 26 that senior loans saw their third consecutive year of strong performance in 2025 and the ninth positive year of the last 10, as measured by the S & P UBS Leveraged Loan Index. "The loan asset class continues to provide high levels of income, even with two Fed rate cuts priced in for 2026," she wrote. The Invesco Senior Loan ETF (BKLN) was the first bank loan ETF on the market and is the largest, with about $7.3 billion in assets, Moriarty said. It has a 30-day SEC yield of 5.88% and a 0.65% net expense ratio. The passively managed ETF, with three stars and bronze ratings from Morningstar , is in the bottom quartile rank among its peers year to date, but ...

Gaming-related stocks were punished on AI disruption fears. Shares of mobile game advertising engine Applovin (APP +7.97%) plunged this week, falling 14.9% this week through Friday as of 3:15 p.m. EDT, according to data from S&P Global Market Intelligence. Applovin's stock fell on generalized fear over two new innovations in the mobile game world. Late last week, Alphabet (GOOG 2.44%) (GOOGL 2.47%) unveiled Project Genie, an AI-powered tool that allows users to create virtual worlds. Second, a new AI-based digital advertising start-up, CloudX, became generally available, posing a potential competitive threat to Applovin's mobile game advertising engine. Expand NASDAQ : APP AppLovin Today's Change ( 7.97 %) $ 29.91 Current Price $ 405.14 Key Data Points Market Cap $127B Day's Range $ 381.06 - $ 410.03 52wk Range $ 200.50 - $ 745.61 Volume 232K Avg Vol 4.9M Gross Margin 82.06 % Is the AI genie out of the bottle? The weakness in gaming-related stocks began last Friday, the day after Google rolled out Project Genie to Google AI Ultra subscribers. Virtually all video gaming-related stocks fell in unison after the unveiling, and Applovin got caught up in the sell-off. The actual effect on video game developers is uncertain. Still, of course, Applovin doesn't make mobile games anymore, having sold its video game development business in June 2025 to focus on its digital advertising engine. Still, there could be some effect, given that Alphabet is also a digital advertising giant. If developers create playable gaming worlds entirely with Project Genie and roll them out on a Google gaming platform, Alphabet may insist any Genie-produced games use Alphabet's digital ad engine. While the Project Genie fear spilled over into this week, another potential competitive threat emerged on Wednesday: start-up CloudX. This digital programmatic ad company uses generative AI in place of engineers and operations teams to streamline ad auctions of the kind Applovin holds. CloudX founder Jim...

Nvidia (NVDA) Pops as Huang Doubles Down on a $660B Capex Wave Wall Street Pit

Which of the highest-yielding healthcare stocks are value traps or golden opportunities? With healthcare's status as a recession-resistant industry, healthcare stocks can be a great place for dividend investors to find companies paying out steady, consistent dividends. However, it's not as if you can just buy only high-yield dividend stocks and call it a day. In this space, there are plenty of potential yield traps and value traps. Such stocks, already beaten down by negative news and sentiment, are at risk of further declines, not to mention dividend cuts and suspensions. Among U.S.-listed healthcare stocks with market caps of at least $200 million, the three highest-yielding are Perrigo (PRGO +2.59%), Pfizer (PFE +2.74%), and Embecta (EMBC +3.82%). Let's take a look at each and decide whether they make great choices for dividend investors. As value trap vibes persist, tread carefully with Perrigo Perrigo makes and sells over-the-counter health and wellness products. While a strong performer during the late 2010s through early 2010s, shares have experienced a steep slump over the past decade. Shares have dropped by 90% during this time frame. Just over the past year alone, Perrigo has fallen by 41%. Chalk this up to declining sales, weak guidance, and analyst downgrades . This massive price decline is a big reason why Perrigo has become a high-yielder. Expand NYSE : PRGO Perrigo Plc Today's Change ( 2.59 %) $ 0.37 Current Price $ 14.64 Key Data Points Market Cap $2.0B Day's Range $ 14.21 - $ 14.71 52wk Range $ 12.17 - $ 30.93 Volume 59K Avg Vol 3.6M Gross Margin 35.43 % Dividend Yield 8.13 % Currently, the stock has a forward dividend yield of 8.2%. Perrigo's dividend payout ratio is only 41.6%. The company also has a 23-year track record of dividend growth, and trades for less than 6 times forward earnings. Yet even if its high payout is here to stay, tread carefully. Until positive news emerges, it may be best to assume shares remain a value trap. Pfizer remains ...

J Studios/DigitalVision via Getty Images In my last coverage on Strategy Inc. ( MSTR ), I decided to stay on the sidelines and not buy the dip. After the company released Q4 earnings yesterday and after MSCI announced today that it did not proceed with its initial proposal to exclude DATCOs from indexes, the stock is up double digits. To me, this is another clear example that, for some stocks, fundamentals mostly don't matter. You may report a $17.4B unrealized loss on digital assets, but the moment there’s a positive narrative to hold onto, the stock rallies. After these recent developments, I still reiterate my Hold rating on the company. Why? I simply see a more pure exposure to Bitcoin ( BTC-USD ) through some of the U.S. spot Bitcoin ETFs, which have been reported to experience an outflow of over $3B in January, following outflows of about $2 billion and $7 billion in December and November. On top of that, I am not an institutional investor, and I'm not restricted on what assets I can own. Therefore, I am not limited to buying equities like Strategy or GameStop ( GME ) to get exposure to Bitcoin. In this piece, I explain a key risk that I see in the near term related to mNAV and why I'm not bearish on Strategy, even though I am not buying the dip. The mNAV Discount Is Breaking the BTC-per-share Accretion Narrative Let me first explain two metrics used among analysts to analyze Strategy. These are the Bitcoin NAV value and the mNAV. From an earlier financial report last year, here is how the company defines the Bitcoin NAV value: “Bitcoin NAV” for these purposes means the market value of our bitcoin holdings calculated by multiplying the current market price of one bitcoin by the total number of bitcoins that we hold. Although it incorporates the label “NAV,” it is not equivalent to “net asset value” or “NAV” or any similar metric in the traditional financial context. The other relevant metric is the mNAV. Here is the official definition from that report: mNAV r...

Source: Bloomberg, 0:00

In a stunning blow for gamers, it seems that for the first time in decades, Nvidia (NVDA) might look to skip launching a fresh gaming GPU this year. The tech behemoth is looking to forgo a 2026 gaming release due to the ongoing memory supply crunch, according to The Information. Unsurprisingly, ...

In early February 2026, the tech sector saw a sharp and sudden valuation reset, with nearly $300 billion in market capitalization wiped out in roughly a single trading day. The declines were concentrated in software, data services, and IT outsourcing stocks. The trigger was Anthropic’s release of Claude Cowork, a set of open-source plugins that enable AI agents to execute tasks autonomously, end-to-end, using raw inputs rather than operating inside existing software workflows. Demonstrations showed the system independently conducting legal research and drafting filings. This likely changes the narrative of AI from a mere productivity enhancer into a direct substitute for entire layers of software and services. The scale of the sell-off raises a critical question for investors: if so much value was destroyed so quickly, where exactly could it be reallocated? In the medium term, markets rarely erase hundreds of billions of dollars without simultaneously pricing in new winners. So how should investors play this shift? The sell-off is a reminder that individual stocks can be volatile and shake you out, but strategic allocation and diversification help you stay invested. Our Boston-based wealth management partner’s asset allocation approach is designed exactly for that. Which sectors of the market were badly hit? Seat-Based SaaS: Giants like Salesforce (NYSE:CRM), ServiceNow, and Adobe (NASDAQ:ADBE) saw 6% to 8% declines. These companies typically charge “per user.” If AI agents make one human as productive as ten, the total number of “seats” required by an enterprise drops precipitously. IT Services (Outsourcing): Indian firms like Infosys and TCS were hit hard. Their revenue model relies on billing hours for manual data tasks and junior-level coding, which are the exact tasks Claude’s new plugins could potentially automate. High-Margin Data Providers: Stocks like Thomson Reuters and LegalZoom fell 15% to 20% as investors priced in the risk that autonomous AI can handle...

Palantir Technologies (PLTR) just delivered what CEO Alex Karp called a “truly iconic” performance in its Q4. The stock briefly popped after the company crushed Wall Street estimates and issued 2026 guidance that feels more like science fiction than reality. But as a risk manager, you have to look past the post-earnings glow. While the rally was impressive, the stock is fighting a multi-year history of volatility and a valuation that puts it in a category of one — for better or worse. And then, PLTR gave it all back and more. Followed up by rallying 5% on Friday morning. What else is new? I’ve come to regard PLTR as a symbol of the modern stock market. The way it is discussed, the boldness and arrogance of the CEO, and the thrills and spills that are part and parcel of being a PLTR shareholder. The longer-term chart picture, as in a daily view, shows just how much this stock is “juiced” in both directions. Since last July 4, the stock has essentially roundtripped from $136 to $200 and back to $136. And while the Percentage Price Oscillator (PPO) is as low as it has been over the past 12 months, the 20-day moving average (in red, top of chart) is still in deep decline. Translation: it will take more than a few days’ rally to turn this ship around. What’s the Bull Case for PLTR Stock? In software, the “Rule of 40” (revenue growth + profit margin) is the gold standard. In Q4, Palantir hit a staggering 127%. This was driven by a 70% year-over-year revenue surge and a massive 93% growth in its U.S. business. When a multibillion-dollar company accelerates its growth rate while increasing its profit margins to 57%, the market is going to reward it with a massive pop. At least for a little while. Then, the expectations move up with the stock price. For years, the bear case was that PLTR was just a government consultant with no scalable product. But with U.S. commercial revenue flying higher by more than 130% year-over year in the last report, there’s hard proof that compani...

Palantir Technologies (PLTR) just delivered what CEO Alex Karp called a “truly iconic” performance in its Q4. The stock briefly popped after the company crushed Wall Street estimates and issued 2026 guidance that feels more like science fiction than reality. But as a risk manager, you have to look past the post-earnings glow. While the rally was impressive, the stock is fighting a multi-year history of volatility and a valuation that puts it in a category of one — for better or worse. More News from Barchart And then, PLTR gave it all back and more. Followed up by rallying 5% on Friday morning. What else is new? www.barchart.com I’ve come to regard PLTR as a symbol of the modern stock market. The way it is discussed, the boldness and arrogance of the CEO, and the thrills and spills that are part and parcel of being a PLTR shareholder. The longer-term chart picture, as in a daily view, shows just how much this stock is “juiced” in both directions. Since last July 4, the stock has essentially roundtripped from $136 to $200 and back to $136. And while the Percentage Price Oscillator (PPO) is as low as it has been over the past 12 months, the 20-day moving average (in red, top of chart) is still in deep decline. Translation: it will take more than a few days’ rally to turn this ship around. www.barchart.com What’s the Bull Case for PLTR Stock? In software, the “Rule of 40” (revenue growth + profit margin) is the gold standard. In Q4, Palantir hit a staggering 127%. This was driven by a 70% year-over-year revenue surge and a massive 93% growth in its U.S. business. When a multibillion-dollar company accelerates its growth rate while increasing its profit margins to 57%, the market is going to reward it with a massive pop. At least for a little while. Then, the expectations move up with the stock price. For years, the bear case was that PLTR was just a government consultant with no scalable product. But with U.S. commercial revenue flying higher by more than 130% year-ove...

The broader market passed a significant milestone thanks to big gains for stocks outside of tech. Goldman Sachs and Caterpillar are examples.

美联储数据显示，12月消费者信贷按年率增长5.7%，达到5.109万亿美元。 循环信贷增长138亿美元，至1.329万亿美元。 非循环信贷增加102亿美元，至3.781万亿美元。 责任编辑：李桐

Few analysts foresaw the disappointing results and profit forecast that sent Boston Scientific Corp. ’s shares plummeting nearly 20% this week. Even fewer have given up on their bullish calls since. It’s a development that has surfaced time and again in the past year, and one that investors say throws into sharp relief a fundamental problem with equity research: how Wall Street’s almost unfailingly positive analysis often leaves investors blindsided when trouble hits. The medical device maker’s stock is on pace for its worst weekly decline since 2008, after it underwhelmed investors with its adjusted profit forecast for 2026 and posted growth numbers for its Electrophysiology segment in the fourth quarter that fell short of consensus expectations. Its 18% drop on Wednesday, when the company reported earnings, was its biggest daily loss in more than 25 years. Wall Street had been overwhelmingly positive on the stock before its earnings report, with 35 out of 37 analysts tracked by Bloomberg rating it as a “buy.” Analysts, however, are far from contrite: The number of “buys” has grown by one and the average price target still stands some 38% above where the stock trades today, Bloomberg data show. Bulls say they expect revenues at Boston Scientific to keep growing and that the slide in its shares only makes them more attractive. Yet the selloff also echoes last year’s tumbles in analyst favorites such as Fiserv Inc. and UnitedHealth Group Inc. Like Boston Scientific, both companies sported nearly wall-to-wall “buy” ratings, reflecting a larger trend: Data compiled by Bloomberg show some 59% of analyst ratings on S&P 500 companies are “buys” and just over 5% “sells.” Boston Scientific did not respond to a request for comment. UnitedHealth’s Plunge Blindsided Analysts Across Wall Street Fiserv’s Lone Bear Sounded Alarm Long Before Stock’s Plunge Still Bullish Leerink Partners analyst Mike Kratky wrote that the results created “heightened uncertainty on the trajectory of...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At Galaxy Digital, a filing with the SEC revealed that on Wednesday, Director Douglas R. Deason bought 25,000 shares of GLXY, at a cost of $20.80 each, for a total investment of $519,950. Investors can grab GLXY even cheaper than Deason did, with shares trading as low as $18.90 at last check today -- that's 9.1% under Deason's purchase price. Galaxy Digital is trading up about 19.2% on the day Friday. Before this latest buy, Deason purchased GLXY at 2 other times during the past twelve months, for a total investment of $1.03M at an average of $30.23 per share. And on Tuesday, David J. Volk bought $503,280 worth of California BanCorp, buying 27,000 shares at a cost of $18.64 each. California BanCorp is trading up about 1.6% on the day Friday. So far Volk is in the green, up about 3.7% on their buy based on today's trading high of $19.32. VIDEO: Friday 2/6 Insider Buying Report: GLXY, BCAL The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The world's top cryptocurrency is stuck in the penalty box. Bitcoin's (BTC +10.90%) price recently dropped below $70,000. It's now pulled back more than 40% from its all-time high last October and has given up all its gains since President Trump won the election on Nov. 5, 2024. That sell-off can be attributed to elevated Treasury yields, a murky outlook for future interest rate cuts, and other macro headwinds -- which all drove investors to book profits and rotate toward more conservative investments. As Bitcoin's price plunged, leveraged liquidations at key support levels accelerated the sell-off. That's why many investors might feel like a deer stuck in the headlights right now. However, I think the smartest move Bitcoin's long-term investors can make today is to simply do nothing. Why should Bitcoin's investors do nothing? Bitcoin is a notoriously volatile investment. Looking back at the past five years, we've already seen it sink from $68,000 in November 2021 to a multi-year low of around $16,000 in November 2022, then rally to a record high of more than $126,000 in October 2025. Plenty of investors likely panicked and sold their Bitcoin at $16,000, or desperately chased it when it hit $126,000. So instead of hopping on the bearish or bullish bandwagon, it made more sense to take the contrarian view both times. But since it's impossible to tell how low Bitcoin will actually drop before it bottoms out, it's too risky for investors to aggressively buy it right now. So if you're still bullish on Bitcoin, it's smarter to do nothing, wait for it to rebound, and accumulate more as it rallies again. Expand CRYPTO : BTC Bitcoin Today's Change ( 10.90 %) $ 6942.75 Current Price $ 70620.00 Key Data Points Market Cap $1.4T Day's Range $ 60256.00 - $ 71258.00 52wk Range $ 60256.00 - $ 126079.89 Volume 147B Why could Bitcoin rally even higher over the long term? Bitcoin is under significant pressure, but the bullish thesis remains intact. It will become harder to mine with ...

Key Points Dave now expects 60% revenue growth in 2025. The online bank's adjusted earnings are rising even faster. 10 stocks we like better than Dave › Shares of Dave (NASDAQ: DAVE) climbed on Friday after the branchless bank announced preliminary financial results for the fourth quarter. As of 2:30 p.m. EST, Dave's stock price was up more than 16%. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Rapid sales growth and improving profitability Dave now sees its net operating revenues rising by 62% to $164 million in the fourth quarter. The financial technology company also expects its earnings before interest, taxes, depreciation, and amortization (EBITDA) to jump 118% to $73 million. "Q4 represented our third consecutive quarter of 60%+ revenue growth, driven by accelerating monthly transacting member growth, continued ARPU [average revenue per user] expansion, and strong underlying demand for our products," CEO Jason Wilk said in a press release. For the full year, management anticipates net operating revenues of $554 million and adjusted EBITDA of $227 million in 2025, up from a prior forecast of roughly $546 million and $217 million, respectively. These new projected results would represent growth of 60% and 162%. "The operating leverage embedded in our model continued to strengthen throughout 2025: full-year adjusted EBITDA grew over 160%, nearly three times our revenue growth rate, a direct result of strengthening unit economics and deepening member relationships while maintaining our discipline on fixed costs," Wilk said. Dave's upcomingearnings callshould provide more details Investors can expect to hear more about the progress of Dave's growth initiatives when it reports its finalized fourth-quarter results on March 2. Management plans to hold a conference call with investors that same da...

Apple (AAPL) Sees Increased Options Activity Amid Bullish Sentim GuruFocus

Key Points Medicare eligibility typically begins at 65. If you find yourself out of work sooner, it's important to make sure you have health insurance. Some options to consider include a spouse's plan, COBRA, and Medicaid. The $23,760 Social Security bonus most retirees completely overlook › There's a reason many older Americans wait until age 65 or later to retire. Not only does waiting until 65 allow you to boost your retirement savings, but it can also make for a smoother transition as far as healthcare coverage is concerned. Medicare eligibility generally begins at age 65. If you retire sooner, you could end up in a tough situation with regard to medical insurance. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » But what if you're forced into retirement before turning 65? If your company downsizes when you're 64, for example, you may, at that point, struggle to find a new job. Or at that stage of life, it may not be worth it to have to learn the ropes at a new place of work. One thing you don't want to do in a situation like this is go without health insurance. A single accident could leave you with horrendously high bills if you end up needing emergency care. Here are some health coverage options you can look at if you end up retiring before being able to enroll in Medicare. 1. Join a spouse's workplace plan If you have a spouse who's still working, joining their workplace plan may be an option. Even if it's outside of your spouse's general enrollment period for health insurance at work, you may be eligible for a special enrollment window due to losing your coverage. 2. Get coverage through COBRA COBRA allows people to retain employer health coverage for a limited period of time -- usually up to 18 months. If that's enough time to bridge the gap until your 65th birthday, it's an option you ma...

Jacob Wackerhausen/iStock via Getty Images U.S. consumer credit surged by $24.05B in December, compared to the $8.4B gain expected and 4.70B increase in November (revised from $4.23B), according to data released by the Federal Reserve on Friday. Consumer borrowing rose at a 5.7% seasonally adjusted annual rate in December to $5.11 trillion. Revolving credit was up at a 12.6% annual rate to $1.33 trillion, and nonrevolving credit advanced at a 3.2% annual rate to $3.78 trillion, the Fed said. More on U.S. Economy ‘There’s no demand for labor’ – MetLife’s Drew Matus Fed's Jefferson flags productivity as key disinflationary force Consumer sentiment edges up in February as year-ahead inflation expectations dip